High CD34+ Cell Counts Decrease Hematologic Toxicity of Autologous Peripheral Blood Progenitor Cell Transplantation
Published in Blood • May 1, 1998
NobleIDNI0P26W84R32S09
Authors:,,
Nicolas Ketterer
Gilles Salles
Michel Raba
Abstract
Optimal numbers of CD34+ cells to be reinfused in patients undergoing peripheral blood progenitor cell (PBPC) transplantation after high-dose chemotherapy are still unknown. Hematologic reconstitution of 168 transplantations performed in patients with lymphoproliferative diseases was analyzed accord...